期刊文献+

胃癌D _4根治术 被引量:4

Superextended lymphadenectomy(D_4) in the treatment of gastric adenocarcinoma
原文传递
导出
摘要 目的 探讨胃癌D4根治术的临床意义。方法 总结 1997年 10月至 2 0 0 3年 10月 5 2例胃癌D4根治术的经验 ,通过无瘤接触、杀瘤技术、手术技巧、淋巴结的阳性率、TNM分期及治疗预后等资料进行分析。结果 胃大部分切除术 4 8例 ,全胃切除 4例 ,全部治愈出院。共清除淋巴结 883个 ,其中淋巴结转移71 2 % ;37例有淋巴结转移及有 1例No .16转移。Ⅰb期占 2 8 9% ,Ⅱ期占 15 4 % ,Ⅲa期占 19 2 % ,Ⅲb期占 11 5 % ,Ⅳ期占 2 8 9%。其 1、2、3年的生存率分别为 84 6 %、71 2 %及 5 5 7%。结论 D4术式是一种安全、可行及有效的术式 ,可提高Ⅰ、Ⅱ、Ⅲa期的生存率 ,其不但能精确TNM分期 。 Objective To investigate the clinical meaning of D 4 radical treatment in gastric cancer.Methods We summarized 52 cases of gastric cancer under D 4 radical therapy from October 1997 to October 2003.Data of non tumor contact technic,technic of tumor suide,operation technic,positive rate of lymph node,TNM classification and treatment,prognosis were analyzed.Results Subtotal gastrectomy acounted for 48 cases and total gastrectomy,4 cases.All cured and discharged.883 lymph nodes were extirpated,lymphtic nodes metastases was 71.2%.Among them 37 cases were found with lymph nodes metastasis and one patient,with N 4 metastasesthere.Stage Ⅰb acounted for 28.9% and stage Ⅱ 15.4%,Ⅲa 19.2%,Ⅲb 11.5%,and stage Ⅳ 28.9%.The 1~,2~,3~ year survival rate were 84.6%,71.2% and 55.7% respectively.Conclusion D 4 lymphadenectomy for gastri cancer is a safe,reasonable and effective method for increasing the survival rate in Ⅰ,Ⅱ,Ⅲa stage patient.It not only helps in accurately classif TNM type,but also promotes exchanges of academic experiences.
出处 《中国基层医药》 CAS 2004年第3期276-278,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 广东顺德市科技计划项目 (2 0 0 1 67)
关键词 胃癌 D4术式 根治术 手术技巧 预后 肿瘤分期 Gastric cancer Surgical treatment D 4 lymphadenectomy
  • 相关文献

参考文献3

二级参考文献15

  • 1陈峻青 齐春莲 单吉贤 等.胃癌浆膜的分型及其意义[J].中华医学杂志,1986,66:736-736.
  • 2徐光炜 吴阶平 裘法祖 主编.胃癌[A].吴阶平,裘法祖,主编.黄家驷外科学:第6版[C].北京:人民卫生出版社,2000.1046-1049.
  • 3徐光炜.胃癌.见张天泽,徐光炜主编.肿瘤学(中册)[M].第1版.北京:人民卫生出版社,1993:1477.
  • 4Wilke H,Preusser P,Fink U,et al.Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide,doxorubicin,and cisplatin.J Clin Oncol,1989,7:1318-1326.
  • 5Fujimura T,Yonemura Y,Muraoka K,et al.Continuous hyperthermic perthrmic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer.Randomized controlled study.World J Surg,1994,18:150 155.
  • 6Nakazato H,Koike A,Saji S,et al.Efficacy of immunoche motherapy as adjuvant treatment after curative resection of gastric cancer.Lancet,1994,343:1122-1126.
  • 7Tanaka Y,Migita T,Sakamoto H,et al.Standard surgical treatment of gastric cancer.Nippon Rinsho.2001,59:331-336.
  • 8Setala LP,kosma VM,Marin S,et al.Prognostic factors in gastric cancer:the value of vascular invasion,mitotic rate and lymphoplasmacytic infiltration.Br J Cancer,1996,74:766-772.
  • 9Roukos DH,Lorenz M,Encke A,et al.Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept:a prospective long term follow up study.Surgery,1998,123:573-578.
  • 10Manzoni G,Verlato G,Guglielmi A,et al.Prognostic significance of lymph node dissection in gastric cancer.Br J Surg,1996,83:1604-1607.

共引文献19

同被引文献22

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部